Navigation Links
Medstrat Announces Record Sales Year
Date:1/21/2011

DOWNERS GROVE, Ill., Jan 21, 2011 /PRNewswire/ -- Medstrat, a pioneer in medical imaging for almost 15 years and the leading developer of FDA-approved orthopedic multi-platform PACS and imaging solutions, announces record sales for the year ended December 31, 2010. During the year, Medstrat added over 100 new PACS customers to its already significant base of orthopedic practices throughout the United States. As a result, both sales revenue and net income hit record levels. According to Michael Cowden, Medstrat's President & CEO, "Our strong performance in 2010 is a direct result of the team we have here in place at Medstrat. Truly caring about our customers is what we are all about.  It is our culture and it is directly influencing our growth, especially in light of the tremendous number of referral opportunities available due to recent failures by large competitors and continued ownership changes by others." According to Mr. Cowden, PACS conversions represent a significant percentage of current business and will continue to do so throughout 2011.  He also attributes recent success to continued strong business relationships throughout the orthopedic PACS industry.

About Medstrat

Medstrat originated digital x-ray imaging for orthopedic practices to meet the unique needs of the orthopedic surgeon and address the demanding challenges orthopedic surgeons face every day, including the pressure to reduce costs and deliver faster, higher-quality patient care. Based upon a proven, high-performing digital medical imaging platform, Medstrat allows for the elimination of film, chemicals, and processing, increases workflow efficiency and staff productivity, and provides significant cost savings. For more information, call 800-882-4224 or visit www.medstrat.com.


'/>"/>
SOURCE Medstrat
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Medstrat Partners with Major Orthopedic Company
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... June 7, 2017 Endo International plc (NASDAQ: ... 2017, the Hon. Joseph R. Goodwin , U.S. ... West Virginia , entered a case management ... Repair System Products Liability Litigation (the "MDL") that includes ... to provide expert disclosures on specific causation within one ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
(Date:5/30/2017)... May 30, 2017 Therapix Biosciences Ltd. (Nasdaq: ... in the development of cannabinoid-based drugs, today announced ... overview at three upcoming scientific and investor conferences ... Micro Invitational: ... Date:                     Wednesday, ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation Act ... harm to people with all chronic conditions, including mental illnesses, while increasing the ... the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it does ...
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or from ... how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional supplements, ... symptoms of AMD? A study published recently in Dove Medical Press journal, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend and veteran ... the JFK Virgin Atlantic lounge. , Bensko is no stranger to the plight ... Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, her riveting ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Aesthetic Channel has recently highlighted ... has come up with a proprietary technique that he calls the AuraLyft ... dropped. For all ages, patients can expect to look refreshed, rejuvenated, and revitalized. ...
(Date:6/23/2017)... ... ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows , ... society in 11 countries across the Middle East and South Asia to embark on ... knowledge and ideas with the leading minds in their fields. , For the ...
Breaking Medicine News(10 mins):